Conceptio
›
Archive
›
HAL (France)
HAL (France)
open access
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial
George Lau et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1, 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
A dynamic leaf gas-exchange strategy is conserved in woody plants under changing ambient CO<sub>2</sub>: evidence from carbon isotope discrimination in paleo and CO<sub>2</sub> enrichment studies
#1053610
Fine-scale genetic structure and diversity in native and introduced Arctic charr populations
#1053611
Reconfiguring Product Designer Competencies in the Age of Artificial Intelligence: Towards a Pedagogy of Mediation in Project Workshops
#1053612
Que sait-on des risques sanitaires et environnementaux des micro et nanoplastiques ?
#1053613
Gagny (Ile-de-france, Seine-Saint-Denis) 9, avenue Fournier. Rapport de diagnostic archéologique, 2024
#1053614
Record
· ID 326315
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.